An observational study in Epiretinal Membrane, sponsored by Kyorin University. Completed at 1 site in Japan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-12-11.
Sponsored by Kyorin University · Observational
Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment. Investigators evaluate whether presence of FAF may correlate to the postoperative visual outcome for epiretinal membrane.
92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal and internal limiting membrane (ILM) peeling. Presence of hyperfluorescence in FAF at the macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at postoperative 1, 3, and 6 months with ultra-wide angle imaging.
120 studies on the registry are indexed under Epiretinal Membrane; 14 are open to participants now.
This study's enrollment of 91 is above the median of 60 across 45 observational studies indexed under Epiretinal Membrane.
Browse Epiretinal Membrane studies →Kyorin University is the lead sponsor of 33 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
The patients with epiretinal membrane who underwent vitrectomy with epiretinal membrane and internal limiting membrane removal
Exclusion Criteria:
Vitrectomy with removal of epiretinal membrane and internal limiting membrane
Visual acuity before and after surgery
Vision
Time frame: Changes from baseline to 1, 3, 6 months
Presence of fluids autofluorescence at the macular area
Fundus autofluorescence
Time frame: Changes from baseline up to 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kyorin University